Anti-LILRB4 CAR T cells have demonstrated potent anti-cancer effects in vitro and in xenograft mouse models of AML, without toxicity towards normal hematopoietic cells [143]. The gene discussed is LILRB4; the disease is acute myeloid leukemia.